Pharmaceutical preparations company · DE · FY ends Dec · Revenue $1.11B · 14.95% margin · $38M FCF
Operating margin is thin at 5.52%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue up 28.5% YoY with margins expanding 26.6pp.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$1.11B
▲ +28.5% YoY
Net Income (TTM)
$133M
▲ +111.3% YoY
Op. Margin
14.95%
▲ +26.6pp YoY
ROIC
43.23%
▲ +55.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$38M
▲ +151.0% YoY
Op. Cash Flow (TTM)
$38M
▲ +151.6% YoY
Net Debt
-$385M
Net Cash Position
Cash & Equiv.
$405M
5Y CAGR: +32.0%
Continue Research